{"id":7087,"date":"2023-11-23T11:48:15","date_gmt":"2023-11-23T14:48:15","guid":{"rendered":"https:\/\/acrisure.com.br\/insights\/?p=7087"},"modified":"2026-02-24T12:23:27","modified_gmt":"2026-02-24T15:23:27","slug":"ans-cancer-intestino","status":"publish","type":"post","link":"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/","title":{"rendered":"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Post&#8221; _builder_version=&#8221;4.20.0&#8243; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row admin_label=&#8221;Post&#8221; _builder_version=&#8221;4.23&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; width=&#8221;100%&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text admin_label=&#8221;Conte\u00fado&#8221; _builder_version=&#8221;4.27.2&#8243; _module_preset=&#8221;default&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span style=\"font-weight: 400;\">Em nova atualiza\u00e7\u00e3o, a Diretoria Colegiada da <a href=\"https:\/\/www.gov.br\/ans\/pt-br\/assuntos\/noticias\" target=\"_blank\" rel=\"noopener\">Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS)<\/a> aprovou a inclus\u00e3o do <span class='tooltipsall tooltip_post_id_custom_0076ecf4ac2a28af2b2e7757c070ea79 classtoolTipsCustomShortCode' style='border-bottom:2px dotted #888;'>Encorafenibe<\/span><script type=\"text\/javascript\">jQuery(\"document\").ready(function(){ toolTips('.tooltip_post_id_custom_0076ecf4ac2a28af2b2e7757c070ea79','O Encorafenibe \u00e9 um medicamento para o c\u00e2ncer que interfere no crescimento e dissemina\u00e7\u00e3o de c\u00e9lulas cancerosas no corpo\\.'); });<\/script> combinado ao cetuximabe ao rol de procedimentos com cobertura obrigat\u00f3ria pelos planos particulares.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Ambos os medicamentos s\u00e3o utilizados para tratamento do c\u00e2ncer colorretal (parte do intestino), <strong>e ter\u00e3o sua cobertura obrigat\u00f3ria a partir do dia 01\/12\/2023.<\/strong><\/span><\/p>\n<h2><b>Recentes incorpora\u00e7\u00f5es da ANS do Rol\u00a0<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Em outubro a ANS tamb\u00e9m aprovou a incorpora\u00e7\u00e3o ao Rol de Procedimentos e Eventos em Sa\u00fade das seguintes tecnologias:\u00a0<\/span><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\"> Encorafenibe, em combina\u00e7\u00e3o com Binimetinibe, para o tratamento de pacientes adultos com melanoma irressec\u00e1vel ou metast\u00e1tico; e\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\"> Lenvatinibe, em combina\u00e7\u00e3o com Pembrolizumabe, para tratamento de pacientes adultas com c\u00e2ncer endometrial avan\u00e7ado.\u00a0<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">As propostas de incorpora\u00e7\u00e3o dessas tecnologias ao Rol foram submetidas diretamente \u00e0 ANS, tendo passado pela 18\u00aa Reuni\u00e3o T\u00e9cnica da Cosa\u00fade, realizada em julho, e pela Consulta P\u00fablica 114, bem como por criteriosa an\u00e1lise t\u00e9cnica, que utiliza metodologia de avalia\u00e7\u00e3o de tecnologias em sa\u00fade (ATS).<\/span><\/p>\n<p><span style=\"font-weight: 400;\">As tecnologias <strong>passaram a ter sua cobertura obrigat\u00f3ria em 1\/11,<\/strong> e j\u00e1 constam no Rol, de acordo com suas diretrizes de utiliza\u00e7\u00e3o.\u00a0<\/span><\/p>\n<h4><span style=\"font-weight: 400;\">SOBRE O ROL DA ANS<\/span><\/h4>\n<p><span style=\"font-weight: 400;\">O Rol de Procedimentos e Eventos em Sa\u00fade \u00e9 a lista de coberturas obrigat\u00f3rias pelas operadoras de planos de sa\u00fade a todos os seus benefici\u00e1rios. Ele conta com tecnologias dispon\u00edveis entre terapias, exames, procedimentos e cirurgias que atendem \u00e0s doen\u00e7as listadas na Classifica\u00e7\u00e3o internacional de Doen\u00e7as (CID), da Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS).\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Seu processo de atualiza\u00e7\u00e3o tem sido constantemente aprimorado, com ampla participa\u00e7\u00e3o social e buscando garantir a seguran\u00e7a das tecnologias oferecidas aos consumidores, a partir de bases cient\u00edficas e da sustentabilidade do setor de sa\u00fade suplementar.\u00a0\u00a0<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Em nova atualiza\u00e7\u00e3o, a ANS aprovou a inclus\u00e3o do Encorafenibe combinado ao cetuximabe ao rol de procedimentos obrigat\u00f3rios.<\/p>\n","protected":false},"author":1,"featured_media":5988,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[78],"tags":[95],"class_list":["post-7087","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ans","tag-legislacao"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol<\/title>\n<meta name=\"description\" content=\"Em nova atualiza\u00e7\u00e3o, a ANS aprovou a inclus\u00e3o do Encorafenibe combinado ao cetuximabe, para tratar c\u00e2ncer no intestino, ao Rol.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol\" \/>\n<meta property=\"og:description\" content=\"Em nova atualiza\u00e7\u00e3o, a ANS aprovou a inclus\u00e3o do Encorafenibe combinado ao cetuximabe, para tratar c\u00e2ncer no intestino, ao Rol.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/\" \/>\n<meta property=\"og:site_name\" content=\"Insights \/ Acrisure\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/itsseg\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-23T14:48:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T15:23:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/turbinar-ferramenta-consulta-ans.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"publishouse\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"publishouse\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-cancer-intestino\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-cancer-intestino\\\/\"},\"author\":{\"name\":\"publishouse\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#\\\/schema\\\/person\\\/ae285068bde2d94bbb6b0692760fb361\"},\"headline\":\"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol\",\"datePublished\":\"2023-11-23T14:48:15+00:00\",\"dateModified\":\"2026-02-24T15:23:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-cancer-intestino\\\/\"},\"wordCount\":439,\"image\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-cancer-intestino\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/wp-content\\\/uploads\\\/turbinar-ferramenta-consulta-ans.jpg\",\"keywords\":[\"Legisla\u00e7\u00e3o\"],\"articleSection\":[\"ANS\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-cancer-intestino\\\/\",\"url\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-cancer-intestino\\\/\",\"name\":\"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-cancer-intestino\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-cancer-intestino\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/wp-content\\\/uploads\\\/turbinar-ferramenta-consulta-ans.jpg\",\"datePublished\":\"2023-11-23T14:48:15+00:00\",\"dateModified\":\"2026-02-24T15:23:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#\\\/schema\\\/person\\\/ae285068bde2d94bbb6b0692760fb361\"},\"description\":\"Em nova atualiza\u00e7\u00e3o, a ANS aprovou a inclus\u00e3o do Encorafenibe combinado ao cetuximabe, para tratar c\u00e2ncer no intestino, ao Rol.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-cancer-intestino\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-cancer-intestino\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-cancer-intestino\\\/#primaryimage\",\"url\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/wp-content\\\/uploads\\\/turbinar-ferramenta-consulta-ans.jpg\",\"contentUrl\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/wp-content\\\/uploads\\\/turbinar-ferramenta-consulta-ans.jpg\",\"width\":1920,\"height\":640,\"caption\":\"M\u00e9dico consultando a nova vers\u00e3o da ferramenta de consulta da ANS\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-cancer-intestino\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#website\",\"url\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/\",\"name\":\"Insights \\\/ Acrisure\",\"description\":\"Portal de Not\u00edcias e Conte\u00fado\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#\\\/schema\\\/person\\\/ae285068bde2d94bbb6b0692760fb361\",\"name\":\"publishouse\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g\",\"caption\":\"publishouse\"},\"sameAs\":[\"https:\\\/\\\/acrisure.com.br\\\/insights\"],\"url\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/author\\\/publishouse\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol","description":"Em nova atualiza\u00e7\u00e3o, a ANS aprovou a inclus\u00e3o do Encorafenibe combinado ao cetuximabe, para tratar c\u00e2ncer no intestino, ao Rol.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/","og_locale":"pt_BR","og_type":"article","og_title":"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol","og_description":"Em nova atualiza\u00e7\u00e3o, a ANS aprovou a inclus\u00e3o do Encorafenibe combinado ao cetuximabe, para tratar c\u00e2ncer no intestino, ao Rol.","og_url":"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/","og_site_name":"Insights \/ Acrisure","article_publisher":"https:\/\/www.facebook.com\/itsseg\/","article_published_time":"2023-11-23T14:48:15+00:00","article_modified_time":"2026-02-24T15:23:27+00:00","og_image":[{"width":1920,"height":640,"url":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/turbinar-ferramenta-consulta-ans.jpg","type":"image\/jpeg"}],"author":"publishouse","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"publishouse","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/#article","isPartOf":{"@id":"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/"},"author":{"name":"publishouse","@id":"https:\/\/acrisure.com.br\/insights\/#\/schema\/person\/ae285068bde2d94bbb6b0692760fb361"},"headline":"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol","datePublished":"2023-11-23T14:48:15+00:00","dateModified":"2026-02-24T15:23:27+00:00","mainEntityOfPage":{"@id":"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/"},"wordCount":439,"image":{"@id":"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/#primaryimage"},"thumbnailUrl":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/turbinar-ferramenta-consulta-ans.jpg","keywords":["Legisla\u00e7\u00e3o"],"articleSection":["ANS"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/","url":"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/","name":"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol","isPartOf":{"@id":"https:\/\/acrisure.com.br\/insights\/#website"},"primaryImageOfPage":{"@id":"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/#primaryimage"},"image":{"@id":"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/#primaryimage"},"thumbnailUrl":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/turbinar-ferramenta-consulta-ans.jpg","datePublished":"2023-11-23T14:48:15+00:00","dateModified":"2026-02-24T15:23:27+00:00","author":{"@id":"https:\/\/acrisure.com.br\/insights\/#\/schema\/person\/ae285068bde2d94bbb6b0692760fb361"},"description":"Em nova atualiza\u00e7\u00e3o, a ANS aprovou a inclus\u00e3o do Encorafenibe combinado ao cetuximabe, para tratar c\u00e2ncer no intestino, ao Rol.","breadcrumb":{"@id":"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/#primaryimage","url":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/turbinar-ferramenta-consulta-ans.jpg","contentUrl":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/turbinar-ferramenta-consulta-ans.jpg","width":1920,"height":640,"caption":"M\u00e9dico consultando a nova vers\u00e3o da ferramenta de consulta da ANS"},{"@type":"BreadcrumbList","@id":"https:\/\/acrisure.com.br\/insights\/ans-cancer-intestino\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/acrisure.com.br\/insights\/"},{"@type":"ListItem","position":2,"name":"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol"}]},{"@type":"WebSite","@id":"https:\/\/acrisure.com.br\/insights\/#website","url":"https:\/\/acrisure.com.br\/insights\/","name":"Insights \/ Acrisure","description":"Portal de Not\u00edcias e Conte\u00fado","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/acrisure.com.br\/insights\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/acrisure.com.br\/insights\/#\/schema\/person\/ae285068bde2d94bbb6b0692760fb361","name":"publishouse","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g","caption":"publishouse"},"sameAs":["https:\/\/acrisure.com.br\/insights"],"url":"https:\/\/acrisure.com.br\/insights\/author\/publishouse\/"}]}},"_links":{"self":[{"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/posts\/7087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/comments?post=7087"}],"version-history":[{"count":13,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/posts\/7087\/revisions"}],"predecessor-version":[{"id":10534,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/posts\/7087\/revisions\/10534"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/media\/5988"}],"wp:attachment":[{"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/media?parent=7087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/categories?post=7087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/tags?post=7087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}